Sophia Genetics Sa · NASDAQ:SOPH
Puylaert Kevin sold 216 Sophia Genetics Sa shares (Form 4)
Traded Oct 5, 2026 · Filed Oct 7, 2026
On Oct 5, 2026, Puylaert Kevin (Chief Sales Officer) sold 216 Sophia Genetics Sa shares at an average US$8.04 for US$1,737, leaving 147,732 shares. Filed Oct 7, 2026 (Form 4).
- Sold
- 216 shares
- Price
- US$8.04 average (US$7.92 to US$8.06)
- Value
- US$1,737
- Holding after
- 147,732 shares
- Trading plan
- No
- Role
- Chief Sales Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Ordinary Shares | Sale | 185 | US$8.06 | 147,763 | Direct |
| Oct 5, 2026 | Ordinary Shares | Sale | 31 | US$7.92 | 147,732 | Direct |
Source
Related
- Sophia Genetics Sa
- Puylaert Kevin
- Sophia Genetics Sa shareholders
- Form 4 · Puylaert Kevin · Jul 7, 2026
- Form 4 · Puylaert Kevin · May 20, 2026
- Form 4 · Puylaert Kevin · Apr 21, 2026
- Form 4/A · Puylaert Kevin · Apr 8, 2026
- Form 4 · Puylaert Kevin · Apr 8, 2026
- Form 4 · Xu Zhenyu · Oct 14, 2026
- Form 4 · Menu Philippe · Oct 14, 2026
- Form 4 · Camblong Jurgi · Oct 14, 2026
- Form 4 · Menu Philippe · Oct 7, 2026
- Form 4 · Valente Manuela · Oct 7, 2026